Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues – 25 or more amino acid residues in defined sequence
Patent
1984-10-09
1986-09-02
Phillips, Delbert R.
Chemistry: natural resins or derivatives; peptides or proteins;
Peptides of 3 to 100 amino acid residues
25 or more amino acid residues in defined sequence
530325, C07K 712
Patent
active
046097252
ABSTRACT:
Monoiodinated-tyrosine derivatives of synthetic fragments of mammalian atrial natriuretic factor are biologically active and are useful to determine the mode of biological activity and the effect of derivatization on biological activity.
REFERENCES:
patent: 4448764 (1984-05-01), Smith et al.
patent: 4460559 (1984-07-01), Goldenberg
Gutkowska et al., Biochemical and Biophysical Research Communications, 122(2), 593-601, Jul. 31, 1984.
Kangawa et al., Biochemical and Biophysical Research Communications, 118(1), 131-139, Jan. 13, 1984.
Seidah et al., Proc. Natl. Acad. Sci., USA, 81, 2640-2644, May 1984.
Guttman, Calcitonin, 1980, Proceedings of an International Symposium held in Milan, Oct. 15-17, 1980.
Rittel et al., Experientia, 32(2), 246-248 (1976).
Brady Stephen F.
Napier Mary A.
Nutt Ruth F.
Vandlen Richard L.
Merck & Co. , Inc.
Perrella Donald J.
Pfeiffer Hesna J.
Phillips Delbert R.
LandOfFree
Cardiac atrial peptides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cardiac atrial peptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cardiac atrial peptides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1098173